Clinical Trials Browser

Terminated × INDUSTRY × tazemetostat × Clear all

NCT04179864 2026-03-10

CELLO-1

Phase 1/2 Terminated

102 enrolled 39 charts

Prostatic Neoplasms

NCT04762160 2024-03-25

SYMPHONY-2, A Trial to Examine Combination of Tazemetostat With Rituximab in Subjects With Relapsed/Refractory Follicular Lymphoma

Phase 2 Terminated

5 enrolled 7 charts

Lymphoma, Follicular